Previous 10 | Next 10 |
PD-L1 IHC 22C3 pharmDx can now be used as an aid in identifying TNBC patients for treatment with KEYTRUDA ® (pembrolizumab) in Europe. Agilent Technologies Inc. (NYSE: A) today announced that its PD-L1 IHC 22C3 pharmDx assay is now labelled for use in TNBC in the Eu...
Agilent Technologies Inc. (NYSE: A) will release fourth-quarter fiscal year 2021 financial results after the stock market closes on Monday, November 22. The company will host a live webcast of its investor conference call in listen-only mode on the same day. Details for the webcast:...
William von Mueffling's 13F portfolio value decreased this quarter from $14.85B to $14.67B. Cantillon increased Brunswick Corp while dropping Nielsen Holdings. The portfolio continues to be very concentrated with the top five positions accounting for ~26% of the 13F portfolio. ...
Comprehensive approach adopts Paris Agreement climate targets, clearly defined interim goals and commitment to the Science Based Targets Initiative Agilent Technologies, Inc. (NYSE: A) today announced its commitment to achieve net-zero greenhouse gas emissions no later than 2050...
Agilent Announced as My Green Lab's First 'Transformative Level' Sponsor and First Sponsor of the My Green Lab Certification Program PR Newswire SANTA CLARA, Calif. , Oct. 26, 2021 /PRNewswire/ -- Agilent Technologies Inc. (NYSE: A) announced today that it ha...
The diagnostics and research industry has grown substantially over the past few years owing to the integration of advanced technologies and impressive breakthroughs in the early diagnosis of chronic diseases. And because the industry is expected to continue growing with the rising imperative ...
Agilent Technologies Inc. (NYSE: A) today announced it has received CE-IVD mark approval for the PD-L1 IHC 28-8 pharmDx to guide options for the first-line treatment of adult patients with HER2-negative advanced or metastatic gastric, gastroesophageal junction, or esophageal cancers...
Triumph Group (NYSE:TGI) and Air France Industries KLM Engineering & Maintenance (OTCPK:AFRAF) to form joint venture under the name xCelle Americas, to overhaul nacelles for new generation aircraft at Triumph's Hot Springs, Arkansas repair facility. xCelle Americas will undertake mai...
Quest Diagnostics (DGX) will provide testing using the Ki-67 IHC MIB-1 pharmDx (Dako Omnis) as a companion diagnostic to determine patients eligible for Eli Lilly's (NYSE:LLY) Verzenio, which was approved for certain patients with high risk early breast cancer. On Oct. 13, the FDA approv...
II-VI is a great high-tech conglomerate with interests in many fields. Current TAM and revenue will expand rapidly in coming years. Balance Sheet is bulletproof and of no concern. Valuation is compelling at today's prices. There are very limited risks to overall success an...
News, Short Squeeze, Breakout and More Instantly...
Agilent Technologies Inc. Company Name:
A Stock Symbol:
NYSE Market:
Agilent Technologies Inc. Website:
Technology helps high-throughput labs operate more efficiently Agilent Technologies Inc. (NYSE: A) today announced it has acquired Sigsense Technologies , a San Francisco, California-based startup that uses artificial intelligence and power monitoring to help optimize lab operatio...
Expands Agilent’s end-to-end biopharma solutions that accelerate drug discovery, development, and manufacturing Agilent Technologies Inc. (NYSE: A) today announced it has signed a definitive agreement to acquire BIOVECTRA, a leading specialized contract development and manufacturin...
2024-07-21 07:07:00 ET At long last, Europe has a space rocket, the Ariane 6, able to compete with SpaceX and its ubiquitous Falcon 9. The Ariane 6 isn't a reusable rocket, it arrived four years later than it was supposed to, and it probably costs about twice as much as a Falcon. But fo...